Stage : Actualité Stage en direct - P5 | Bourse Reflex
Accueil > Tags > Stage

  • Toutes les actualités en rapport avec « Stage »

20/06 18:00 Stage - Optimized process book for DHA production is completed at Libourne

15/06 19:30 Stage - GENTICEL TO PRESENT CLINICAL RESULTS OF GTL001 AND PRECLINICAL RESULTS OF GTL002 AT EUROGIN 2016 CONGRESS IN SALZBURG, AUSTRIA

15/06 09:00 Stage - Initial Public Offering on Euronext - first step taken with filing of its Document de base

13/06 18:35 Stage - GENTICEL ANNOUNCES COMPLETION OF TWO MAJOR MILESTONES IN PREPARATION FOR PHASE 3 PROGRAM OF GTL001

08/06 18:35 Stage - Disclosure of the total number of voting rights and shares composing the share capital

01/06 19:00 Stage - GENTICEL ANNOUNCES PUBLICATION IN 'CLINICAL CANCER RESEARCH' OF PHASE 1 TRIAL RESULTS SUPPORTING SAFETY, TOLERABILITY AND IMMUNOGENICITY OF GTL001

31/05 18:00 Stage - 2015/16 EBIT margin of 12.8% - Revenues of EUR340m targeted in 2016/17 on back of full impact of merger between Solucom and Kurt Salmon's European business*

13/05 18:00 Stage - REVENUE FOR THE FIRST NINE MONTHS OF 2015/16

11/05 08:00 Stage - Disclosure of the total number of voting rights and shares composing the share capital

30/04 00:15 Stage - Groupe O2i : Chiffre d'affaires du 1er trimestre 2016 - comptes annuels 2015

28/04 18:35 Stage - BUSINESS UPDATE - FIRST QUARTER 2016

28/04 18:00 Stage - 2015/16 revenues: EUR 233.0m, up 43% year-on-year, of which +15% like-for-like

26/04 18:35 Stage - PUBLICATION OF THE 2015 ANNUAL FINANCIAL REPORT

21/04 19:45 Stage - PUBLICATION OF THE FIRST ISSUE OF GENTICEL'S SHAREHOLDER NEWSLETTER

21/04 18:15 Stage - WALLIX presents Markus Westphal as new Director for Central Eastern Europe and expands presence in Germany, Austria and Switzerland

20/04 18:30 Stage - GENTICEL REPORTS ADDITIONAL RESULTS AT 12 MONTHS FROM PHASE 2 TRIAL OF HPV IMMUNOTHERAPEUTIC CANDIDATE, GTL001

06/04 18:00 Stage - Disclosure of the total number of voting rights and shares composing the share capital

22/03 18:30 Stage - SUCCES DE L'AUGMENTATION DE CAPITAL DE 2,6 M EUR AVEC DPS

18/03 16:30 Stage - European Commission Investigation

14/03 07:00 Stage - GENTICEL ANNOUNCES 2015 ANNUAL RESULTS AND STRATEGIC UPDATE FOR 2016